Thursday, March 24, 2016

BRIEF-Meridian Bioscience says bought Magellan Diagnostics for $66 mln

* Meridian expects Magellan to be accretive to earnings per share during second half of calendar 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)